Skip to main content

Table 1 Properties of human TIMPs, summarizing their activities in inhibiting metzincin metalloproteinases and in modulating phenotypic cell behavior [6]

From: Tissue inhibitors of metalloproteinases

Property

TIMP1

TIMP2

TIMP3

TIMP4

Amino acid residues

184

194

188

194

pI

8.5

6.5

9.1

7.2

Protein kDa

28

22

24 or 27

22

N-glycosylation sites

2

0

1

0

Synapsin gene

SYN1

n/a

SYN3

SYN2

Protein localization

Soluble/cell surface

Soluble/cell surface

Extracellular matrix/cell surface

Soluble/cell surface

Pro-MMP binding

proMMP9

proMMP2

proMMP2, 9

proMMP2

MMPs poorly inhibited

MT1-MMP, MT3-MMP, MT5-MMP, MMP19

None

None

None

ADAM inhibition

ADAM10

ADAM12

ADAM10, ADAM12, ADAM17, ADAM19, ADAM33, ADAMTS1, ADAMTS4, ADAMTS5, ADAMTS2 (weak)

ADAM17, ADAM28

Binding partners

CD63, LRP1/MMP9

α3β1integrin, LRP1

EFEMP1, AngIIR, VEGFR

 

Cell proliferation

↑Erythroid precursors

↑Erythroid precursors

↑Smooth muscle cells and cancer cells

↑Mammary tumor cells

 

↑Tumor cells

↑Tumor cells

 

↓Wilm's tumor cells

  

↑Fibroblasts

  
  

↑Smooth muscle cells

  
  

↓Endothelial cells

  

Apoptosis

↓Burkitt's lymphoma cells

↑Colorectal cancer cells

↓Melanoma

↑Smooth muscle

↑Tumor cells

↑Retinal pigment epithelial cells

 

Tumor angiogenesis

↑Mammary

↓Liver

↓Melanoma

↓Mammary

↓Melanoma

 

Angiogenesis in 3D collagen or fibrin gels

No effect

Inhibits

Inhibits

Inhibits

Tumorigenesis effects

Inhibits

Inhibits

Inhibits

Inhibits

Metastasis effects

Stimulates

  

Stimulates

Genetic defects

 

Idiopathic scoliosis

Sorsby's fundus dystrophy

Kawasaki disease

  1. AngIIR, angiotensin II receptor; EFEMP1, EGF-containing fibulin-like extracellular matrix protein 1; VEGFR, vascular endothelial growth factor receptor